Electrocoagulation syndrome after ESD for colorectal mucosal lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meets the indications for colorectal ESD surgery, and has no other serious systemic diseases such as heart, liver, gallbladder, and pancreas; 2. Age>=18 years, regardless of gender; 3. Normal coagulation function; 4. Volunteer to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women, as well as those who may become pregnant and prepare for pregnancy during clinical trials; 2. The patient also has other serious organic diseases that affect the evaluation of this study, such as severe liver disease, heart disease, kidney disease, etc; 3. Patients who have stopped using antiplatelet and NSAIDS drugs for less than 7 days; 4. Without the ability to engage in autonomous behavior, unable to correctly express one's main complaints, such as mental illness or severe neurosis, and unable to cooperate with this trial; 5. Patients with colorectal submucosal tumors (SMTs); 6. Patients who also participate in other clinical studies that affect the observation of the results of this study; 7. Subjects have clinical data loss or inability to effectively cooperate with follow-up; 8. Other researchers believe that it is not suitable for inclusion in the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of coagulation syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Other complication rates;Postoperative body temperature;postoperative C-reactive protein;Postoperative abdominal pain visual analogue scale (VAS) scale;Postoperative time to remove intestinal decompression and drainage tube, etc.; | — |
Countries
China
Contacts
General Hospital of the Northern Theater of the Chinese People's Liberation Army